ImmunologybioRxiv
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection
M. S. Pampusch, H. M. Abdelaal, E. K. Cartwright…·P. J. Skinner
This study evaluates CAR/CXCR5-T cell therapy in SIV-infected rhesus macaques, showing reduced viral loads and safety, with potential for HIV remission.
DOI 10.1371/journal.ppat.1009831